Nektar Therapeutics - Common Stock (NQ:NKTR)

43.58 UNCHANGED

Delayed Quote Updated: 4:15 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Nektar Therapeutics - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Earnings Scheduled For March 12, 2025 ↗

March 12, 2025

Via Benzinga

Top movers in Friday's after hours session ↗

February 21, 2025

As the regular session of the US market concludes on Friday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Sweet Nektar? ↗

April 22, 2024

NKTR has had a terrible time of it for years, but maybe it’s finally ready to turn around.

Via Talk Markets

Nektar Therapeutics Earnings Preview ↗

March 01, 2024

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

Nektar Therapeutics's Earnings: A Preview ↗

May 07, 2025

Via Benzinga

Assessing Nektar Therapeutics: Insights From 5 Financial Analysts ↗

April 11, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 14, 2025

Via Benzinga

Assessing Nektar Therapeutics: Insights From 4 Financial Analysts ↗

March 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 10, 2025

Via Benzinga

Recap: Nektar Therapeutics Q3 Earnings ↗

November 07, 2023

Via Benzinga

A Preview Of Nektar Therapeutics's Earnings ↗

November 06, 2023

Via Benzinga

This Levi Strauss Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

January 08, 2025

Via Benzinga

Eczema Drug Developer Nektar Gains Analyst Confidence With 400% Upside Potential ↗

November 04, 2024

Piper Sandler initiates coverage of Nektar Therapeutics, citing REZPEG's Treg-focused action as a potential breakthrough for Alopecia areata treatment.

Via Benzinga

10 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 04, 2024

Via Benzinga

NKTR Stock Earnings: Nektar Therapeutics Misses EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

NKTR stock results show that Nektar Therapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

NKTR Stock Earnings: Nektar Therapeutics Meets EPS, Beats Revenue for Q1 2024 ↗

May 09, 2024

NKTR stock results show that Nektar Therapeutics met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 07, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 30, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 11, 2024

Via Benzinga

Biotech's Lawsuit With Eli Lilly Might Catalyze Stock ↗

March 29, 2024

Nektar Therapeutics commenced a Phase 2b clinical trial evaluating its lead product candidate rezpegaldesleukin, in patients with severe to very severe alopecia areata, a disease-causing patchy hair...

Via Talk Markets

Topics Lawsuit

Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 04, 2024

Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its...

Via Benzinga

Earnings Scheduled For March 4, 2024 ↗

March 04, 2024

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its fourth quarter.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 12, 2024

Via Benzinga

The One-Minute Market Report - Saturday, Aug. 12 ↗

August 12, 2023

In this weekly outlook, I examine the asset classes, sectors, and ETFs that led the market higher, and which market segments bucked the trend by moving lower. Signs that market participation is...

Via Talk Markets

Topics ETFs

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 08, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 07, 2023

Via Benzinga

Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 07, 2023

Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of...

Via Benzinga

Why Is Nektar Therapeutics Stock Surging Today? ↗

August 07, 2023

Nektar Therapeutics Inc (NASDAQ: NKTR) said its former partner Eli Lilly And Co (NYSE: LLY) had presented "erroneous data" from two Phase 1b studies of its atopic dermatitis drug,

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 07, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.